Pharmaceutical Evaluation Committee Paper on eConsent Practices and Strategies for Problem Solving
eConsent Information Subcommittee
August 2023
In January 2022, an online survey on eConsent was conducted by the International Trials Department of the National Center for Global Health and Medicine to member companies of the Japan Pharmaceutical Manufacturers Association.
Based on the results of the survey, a paper on eConsent practices and measures to resolve issues was discussed, and the International Trial Department of the NIH and TF3 of the eConsent Committee jointly wrote the paper, which has been submitted, accepted, and published in GHM Open.
▼Published on J-stage
In addition to providing feedback to the member companies of the Japan Pharmaceutical Manufacturers Association who cooperated in the survey, we hope that this document will promote discussions on eConsent not only among pharmaceutical companies but also among parties involved in clinical trials, and promote more patient-centered clinical trials.
We hope that this publication will help to improve the efficiency of clinical trials and promote eConsent in the pharmaceutical industry.
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
eConsent Information Subcommittee, Task Force 3, FY2023
Drug Evaluation Committee Deliverables Back to All Deliverables